International Symposium on Minimal Residual Cancer shared on LinkedIn:
“Professor Christoffer Gebhardt (University Medical Center Hamburg-Eppendorf), Vice Chair of Dermatology and Head of the University Skin Cancer Center Hamburg, is pushing the boundaries of melanoma treatment through ctDNA profiling and biomarker-driven immunotherapy. Catch his insights at ISMRC 2025 in the Liquid Biopsy and Immunotherapy session.
The ISMRC 2025 is organized by Paul Hofman, Catherine Alix-Panabières and Klaus Pantel.”
Explore more about Immunotherapy in Melanoma on OncoDaily:
“Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More”
